Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1451
DELISTED
Faro Technologies
FARO
| $6.83M | 0.01% |
127,342
+121,342
| +2,022% | +$6.36M |
|
|
UFS
1452
DELISTED
DOMTAR CORPORATION (New)
UFS
| $6.82M | 0.01% |
+323,242
| New | +$7.02M |
|
|
ENLC
1453
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $6.81M | 0.01% |
2,791,238
-644,667
| -19% | -$1.33M |
|
1454
Core Laboratories
CLB
$578M
| $6.8M | 0.01% |
334,448
-315,552
| -49% | -$5.66M |
|
1455
Banc of California
BANC
$3.11B
| $6.79M | 0.01% |
627,353
-130,400
| -17% | -$1.31M |
|
1456
Brookfield Renewable
BEP
$10.5B
| $6.79M | 0.01% |
265,954
-279,920
| -51% | -$7.03M |
|
1457
Caesarstone
CSTE
$115M
| $6.79M | 0.01% |
572,678
+197,060
| +52% | +$2.07M |
|
|
AGTC
1458
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.77M | 0.01% |
1,222,240
-176,469
| -13% | -$808K |
|
|
HONE
1459
DELISTED
HarborOne Bancorp
HONE
| $6.75M | 0.01% |
790,335
-6,700
| -0.8% | -$53.6K |
|
1460
GSI Technology
GSIT
$267M
| $6.74M | 0.01% |
938,846
+5,700
| +0.6% | +$41.4K |
|
|
OTIC
1461
DELISTED
Otonomy, Inc.
OTIC
| $6.7M | 0.01% |
1,850,865
-72,100
| -4% | -$188K |
|
|
FLIR
1462
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $6.68M | 0.01% |
164,660
-32,611
| -17% | -$1.35M |
|
1463
Evolution Petroleum
EPM
$135M
| $6.68M | 0.01% |
2,385,172
-8,000
| -0.3% | -$21.5K |
|
1464
MillerKnoll
MLKN
$1.62B
| $6.66M | 0.01% |
281,965
+107,200
| +61% | +$2.42M |
|
1465
InMode
INMD
$874M
| $6.65M | 0.01% |
469,362
+295,762
| +170% | +$3.96M |
|
1466
Ceragon Networks
CRNT
$197M
| $6.64M | 0.01% |
3,087,200
-211,300
| -6% | -$444K |
|
1467
Seres Therapeutics
MCRB
$45.5M
| $6.63M | 0.01% |
69,665
+15,825
| +29% | +$1.39M |
|
1468
Nasdaq
NDAQ
$54.3B
| $6.63M | 0.01% |
166,500
-119,148
| -42% | -$4.44M |
|
1469
STMicroelectronics
STM
$48.4B
| $6.63M | 0.01% |
243,570
-274,054
| -53% | -$6.81M |
|
|
CBD
1470
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $6.62M | 0.01% |
506,700
+365,500
| +259% | +$4.41M |
|
|
SPNE
1471
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $6.6M | 0.01% |
630,500
-21,500
| -3% | -$220K |
|
1472
iShares Gold Trust
IAU
$64.9B
| $6.57M | 0.01% |
+193,350
| New | +$6.34M |
|
1473
Cerence
CRNC
$403M
| $6.55M | 0.01% |
+160,300
| New | +$4.6M |
|
1474
iShares MBS ETF
MBB
$39B
| $6.54M | 0.01% |
59,100
+21,100
| +56% | +$2.34M |
|
1475
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.6B
| $6.53M | 0.01% |
1,136,153
+994,418
| +702% | +$4.64M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.